Parkinsons Disease With Dementia (PDD) Terminated Phase 2 Trials for Nelotanserin (DB12555)

Also known as: Dementia Parkinson's Disease / Parkinson Disease Dementia / Parkinson Disease-Dementia / Parkinson's Disease Dementia / Parkinson Disease Dementia (PDD) / Parkinson's Disease Dementia (PDD) / Parkinson's Disease With Dementia / Parkinsons Disease With Dementia / Dementia With Parkinson's Disease / Parkinson Disease With Dementia

IndicationStatusPhase
DBCOND0122035 (Parkinsons Disease With Dementia (PDD))Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02871427Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior DisorderTreatment